Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ 57.46MNet Cash Flow - Change in Cash & Cash Equivalents
VS
Market
Sector
Industry
History
$ 1.65Close
$ 0.67 - $ 1.82 52-Week Range
Ticker Information
Ticker
CHRSCompany Name
COHERUS ONCOLOGY INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQCOHERUS ONCOLOGY INC - Net Cash Flow - Change in Cash & Cash Equivalents Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
CHRS - CF - Chg. Cash Historical data
| Date | Net Cash Flow - Change in Cash & Cash Equivalents |
|---|---|
| 6/30/2025 | $ 57.46M |
| 3/31/2025 | $ -177.55M |
| 12/31/2024 | $ 22.91M |
| 9/30/2024 | $ 17.24M |
| 6/30/2024 | $ 86.33M |
| 3/31/2024 | $ 243.64M |
| 12/31/2023 | $ 39.36M |
| 9/30/2023 | $ -206.53M |
| 6/30/2023 | $ -202.56M |
| 3/31/2023 | $ -309.54M |
Key Performance Insights, Last 5 Years
- COHERUS ONCOLOGY INC's latest trailing twelve months (TTM) CF - Chg. Cash stands at $ 127.74M.
- Over the past 5 years, COHERUS ONCOLOGY INC's average CF - Chg. Cash has been $ -11.89M.
- The median CF - Chg. Cash for COHERUS ONCOLOGY INC during this period was $ 31.13M
- COHERUS ONCOLOGY INC reached its highest CF - Chg. Cash over the past 5 years at $ 363.69M.
- The lowest CF - Chg. Cash recorded by COHERUS ONCOLOGY INC in the same timeframe $ -353.65M
COHERUS ONCOLOGY INC's CF - Chg. Cash vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CF - Chg. Cash Benchmarks
Similar metrics to CF - Chg. Cash:
- Net Cash Flow - Exchange Rate Changes on Cash - [Cash Flow Statement] Refers to the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.
- Net Cash Flow - Operations - [Cash Flow Statement] Cash flow from operations represents the amount of cash inflow (outflow) that a company generates (consumes) from operating activities. Similar to Net Income [NetIncCmn] but harder to manipulate and ignoring effects of non-cash charges like depreciation.
- Net Cash Flow - Investing - [Cash Flow Statement] The amount of cash inflow (outflow) from investing activities. Investing actives include disposal (expenditure) of capital assets [CapEx], sale (purchase) of business [NCFBus] and of investments [NCFInv].
- Net Cash Flow - Financing - [Cash Flow Statement] The amount of cash inflow (outflow) from financing activities. Financing activities include issuance (purchase) of equity shares, issuance (repayment) of debt, and the payment of dividends.
- Free Cash Flow to Operating Cash Flow - [Calculation] The Free Cash Flow to Cash Flow from Operations ratio, describes how much of a company’s operating cash flow [NCFO] is free to be invested after capital expenditures [CapEx].
Definition of Net Cash Flow - Change in Cash & Cash Equivalents
[Cash Flow Statement] Represents the amount of increase (decrease) in cash and cash equivalents. Includes cash from operations [NCFO], investing [NCFI] and financing [NCFF], adjusted for the effect of exchange rate changes on cash [NCFX]CHRS - Net Cash Flow - Change in Cash & Cash Equivalents, Last 5 years
$ -353.65M
Minimum
Dec 31, 2022
$ 363.69M
Maximum
Dec 31, 2020
$ -11.89M
Average
$ 31.13M
Median
CF - Chg. Cash Benchmark AnalysisMarket
The chart above depicts the distribution of CF - Chg. Cash for companies in the Total Stock Market. The average CF - Chg. Cash of the companies is $ 1.18M with a standard deviation of $ 44.92M.
The following table provides additional summary stats:
CF - Chg. Cash in the Market:
| filtered constituents | 3.34K |
|---|---|
| min | $ -136.09M |
| max | $ 137.58M |
| average | $ 1.18M |
| median | $ 115.89K |
| std | $ 44.92M |